6505-00-062-4827 ( T0FRANIL , NDC00075-3441-65 , NDC00725-0028-10 , NDC00028-0011-51 )
NSN Information
NSN | FSC | NIIN | Item Name | INC |
---|---|---|---|---|
6505-00-062-4827 | 6505 | 000624827 | IMIPRAMINE HYDROCHLORIDE TABLETS | 3080 |
NSN Features
MRC | Parameter | Characteristics |
---|---|---|
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 5000.000 TABLETS |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
FEAT | SPECIAL FEATURES | COATING FEATURE:SUGAR |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS IMIPRAMINE HYDROCHLORIDE ACTIVE INGREDIENT |
CSGS | ADMINISTRATION | ORAL |
Manufacturing Part Numbers (SKUs)
Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
---|---|---|---|---|---|---|---|
T0FRANIL | 97423 | A | 1 | 3 | 6 | 75 | |
NDC00075-3441-65 | 04689 | F | 9 | 5 | 6 | 54 | |
NDC00725-0028-10 | 59389 | Y | 2 | 3 | 6 | 54 | |
NDC00028-0011-51 | 24422 | F | 9 | 5 | 6 | 54 |
Manufacturers
Part SKU | Cage | Manufacturer | Type | Status |
---|---|---|---|---|
T0FRANIL | 97423 | CIBA-GEIGY CORP | A | A |
NDC00075-3441-65 | 04689 | USV PHARMACEUTICAL CORP | A | F |
NDC00725-0028-10 | 59389 | CIRCA PHARMACEUTICAL CO INC | A | Y |
NDC00028-0011-51 | 24422 | CIBA-GEIGY CORP | A | F |
FLIS Identification
PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
---|---|---|---|---|---|---|---|---|---|---|
U | X | A | 1 | 01/01/1 | P | 3004909135 | 3080 |
FLIS Management
MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
---|---|---|---|---|---|
VA | V | K | U/I CONTAINS 5000 TT |
Demilitarization Codes & Management
DML | PMI | HMIC | ADP | CC | ESDC |
---|---|---|---|---|---|
A | U | P | X |
Miscellaneous Management
MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
---|---|---|---|---|---|---|---|---|---|
VA | I | 0 | BT | M | U | V |
Management Control Army
MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
---|
Freight
NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
---|---|---|---|---|---|---|---|---|---|---|---|---|